Thymosin β4, a potential marker of malignancy and prognosis in hepatocellular carcinoma.
Wen-Chao WangXiao-Feng ZhangEr-Jiang TangA-Jian LiLei ChenJia-Qi WangJun-Yong MaXiao-Feng ZhangBin SunPublished in: Scandinavian journal of gastroenterology (2022)
Tβ4 may serve as a novel biomarker for HCC diagnosis and prognosis.
Keyphrases